These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 28656665)
1. Testing for HTLV 1 and HTLV 2 among blood donors in Western Saudi Arabia: prevalence and cost considerations. Hindawi S; Badawi M; Fouda F; Mallah B; Mallah B; Rajab H; Madani TA Transfus Med; 2018 Feb; 28(1):60-64. PubMed ID: 28656665 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia. Ul-Hassan Z; Al-Bahrani AT; Panhotra BR Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814 [TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening. Niazi SK; Bhatti FA; Salamat N J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361 [TBL] [Abstract][Full Text] [Related]
4. Discordant human T-lymphotropic virus screening with Western blot confirmation: evaluation of the dual-test algorithm for US blood donations. Stramer SL; Townsend RL; Foster GA; Johnson R; Weixlmann B; Dodd RY Transfusion; 2018 Mar; 58(3):638-640. PubMed ID: 29322517 [TBL] [Abstract][Full Text] [Related]
5. International forum: Saudi Arabia. Donor screening for HTLV-I in Saudi Arabia: is it cost effective? Bernvil SS; Andrews V; Coulter N Transfus Sci; 1997 Mar; 18(1):45-7. PubMed ID: 10174291 [TBL] [Abstract][Full Text] [Related]
6. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires]. Blejer JL; Saguier MC; Salamone HJ; Carreras LA Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226 [TBL] [Abstract][Full Text] [Related]
7. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia. Fawaz NA; Tamim H; Almawi WY Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of antibodies to human T-lymphotropic viruses types I and II among healthy blood donors. Taha MA; Bashawri LA; Ahmed MS; Ahmed MA Saudi Med J; 2003 Jun; 24(6):637-40. PubMed ID: 12847594 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of human T lymphotropic virus antibodies among healthy blood donors at a tertiary centre in Lagos, Nigeria. Durojaiye I; Akinbami A; Dosunmu A; Ajibola S; Adediran A; Uche E; Oshinaike O; Odesanya M; Dada A; Okunoye O Pan Afr Med J; 2014; 17():301. PubMed ID: 25328597 [TBL] [Abstract][Full Text] [Related]
10. The prevalence of human T-cell leukemia virus in blood donors in China. Li L; Ou S; Huang C; Zhou X; Ge H; Li J; Zeng J; Zhou A; He L; Xu Q; Wu J; Li L; Wang C; Zang L; Huang L; Niu L; Han H; Zhang G; Wan J; Wang F; Xu T; Zhao B; Qian L; Wu Y; Liu Z Transfusion; 2019 Jul; 59(7):2361-2367. PubMed ID: 30985961 [TBL] [Abstract][Full Text] [Related]
11. Saudi National Guard donor screening for human T cell lymphotropic virus I/II: time to use molecular biology techniques. Balkhy HH; Memish ZA; Abed E; Qasem L; Amer AB; Masoud S; Hajeer AH Mil Med; 2004 Mar; 169(3):251-3. PubMed ID: 15080248 [TBL] [Abstract][Full Text] [Related]
12. Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety. Murphy EL Transfus Clin Biol; 2016 Feb; 23(1):13-9. PubMed ID: 26778839 [TBL] [Abstract][Full Text] [Related]
13. HTLV screening of blood donors using chemiluminescence immunoassay in three major provincial blood centers of China. Zhao J; Zhao F; Han W; Xu X; Wang L; Li R; Li T; Wu L; Du D; Zeng X; Cui X; Chen Y; Zeng J; Wang L BMC Infect Dis; 2020 Aug; 20(1):581. PubMed ID: 32762656 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. El-Hazmi MM Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374 [TBL] [Abstract][Full Text] [Related]
15. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France. Couroucé AM; Pillonel J; Lemaire JM; Maniez M; Brunet JB AIDS; 1993 Jun; 7(6):841-7. PubMed ID: 8103342 [TBL] [Abstract][Full Text] [Related]
16. Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand. Oota S; Chaiwong K; Pikulsod S; Khuenkaew R; Pheakkhuntod S; Rattajak P; Kramkratok P; Shiu C; Bhatnagar S; Sakuldamrongpanich T Pathog Glob Health; 2018 Oct; 112(7):343-348. PubMed ID: 30424716 [TBL] [Abstract][Full Text] [Related]
17. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil. Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805 [TBL] [Abstract][Full Text] [Related]
18. Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model. Stigum H; Magnus P; Samdal HH; Nord E Int J Epidemiol; 2000 Dec; 29(6):1076-84. PubMed ID: 11101551 [TBL] [Abstract][Full Text] [Related]
19. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors. O'Brien SF; Goldman M; Scalia V; Yi QL; Fan W; Xi G; Dines IR; Fearon MA Transfus Med; 2013 Oct; 23(5):358-66. PubMed ID: 23859527 [TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of human T-lymphotropic virus type I (HTLV-I) in Saudi Arabia. Arif M; Ramia S Ann Trop Med Parasitol; 1998 Apr; 92(3):305-9. PubMed ID: 9713546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]